Selenium protects cerebral ischemia in rat brain mitochondria

Biological Trace Element Research

Volumn 101, Issue 1, 2004, Pages 73-86

  Ansari, Mubeen Ahmad ^a   Ahmad, Abdullah Shafique ^a,b   Ahmad, Muzamil ^a,b   Salim, Sofiyan ^a   Yousuf, Seema ^a   Ishrat, Tauheed ^a   Islam, Fakhrul ^a  

^a HAMDARD UNIVERSITY   (India)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antioxidant enzymes; Brain mitochondria; Cerebral ischemia; Lipid peroxidation; Monoamine oxidase; Oxidative stress; Poly(ADP ribosyl) polymerase; Sodium selenite

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; ANTIOXIDANT; ANTIOXIDANT ENZYME; CATALASE; CELL ENZYME; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; OXIDIZING AGENT; SELENIUM; SODIUM SELENITE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN MITOCHONDRION; BRAIN PROTECTION; CELL METABOLISM; CONTROLLED STUDY; ENZYME ACTIVITY; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CELL DEGENERATION; NONHUMAN; RAT;

ANIMALS; BRAIN; BRAIN ISCHEMIA; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MITOCHONDRIA; MONOAMINE OXIDASE INHIBITORS; POLY(ADP-RIBOSE) POLYMERASES; RATS; SODIUM SELENITE; THIOBARBITURATES;

ANIMALIA; GYMNOMYZA SAMOENSIS;

EID: 9144228723     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1385/BTER:101:1:73     Document Type: Article

References (59)

1. S. Salim, M. Ahmad, K. S. Zafar, et al., Protective effect of nardostachys jatamansi in rat cerebral ischemia, Pharmacol. Biochem. Behav. 74, 481-486 (2003).
2. Y. Chagnac-Amitai and B. W. Connors, Horizontal spread of synchronized activity in neocortex by GABA-mediated inhibition, J. Eur. Physiol. 61, 747-758 (1989).
3. M. Davis, T. Whitely, D. M. Turnbull, et al., Selective impairment of mitochondrial respiratory chain activity during aging and ischemic brain damage, Acta Neurochir. (Wien) 70(Suppl.), 56-58 (1997).
4. E. Fosslien, Mitochondrial medicine-molecular pathology of defective oxidative phosphorylation, Anal. Clin. Lab. Sci. 31, 25-67 (2001).
5. M. J. Eliasson, K. Sampe, A. S. Mandir, et al., Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia, Nature Med. 3, 1089 (1997).
6. J. Zhang, V. L. Dawson, T. M. Dawson, et al., Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity, Science 263, 687 (1994).
7. L. Virag, A. L. Salzman, and C. Szaboc, Poly(ADP-ribose) synthetase activation mediates mitochondrial injury during oxidant induced cell death, J. Immunol. 161, 3753-3759 (1998).
8. J. Bowes, C. Michelle, J. McDonald, et al., Inhibitors of poly(ADP-ribose) synthetase protects rat cardiomyocytes against oxidant stress, Cardiovasc. Res. 41, 126-134 (1999).
9. P. H. Wang and J. L. Zweir, Measurment of nitric oxide peroxinitrite generation in postischemic heart. Evidences peroxinitrite-mediated reperfusion injury, J. Biol. Chem. 271, 29,223-29,230 (1996).
10. T. Lindahl, M. S. Salob, G. C. Poirier, et al., Post translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks, Trends Biochem. Sci. 20, 405-411 (1995).
11. M. K. Jacobson and E. L. Jacobson, Discovering new ADP-ribose polymer cycles: protecting the genome and more, Trends Biochem. Sci. 11, 415-417 (1999).
12. R. Halmosi, Z. Berente, E. Osz, et al., Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system, Mol. Pharmacol. 59, 1497-1505 (2001).
13. C. Thiemermann, J. Bowes, P. Fiona, et al., Inhibition of poly(ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle, Proc. Natl. Acad. Sci. USA 94, 679-683 (1997).
14. D. A. Carson, S. Set, B. Wasson, et al., DNA strand break, NAD metabolism and programmed cell death, Exp. Cell Res. 164, 273-281 (1986).
15. I. U. Schraufstattar, P. A. Hyslop, D. B. Hinshow, et al., Hydrogen peroxide induced injury and its prevention by inhibition of poly(ADP-ribose) polymerase, Proc. Natl. Acad. Sci. USA 83, 4908-1912 (1986).
16. Keelan, T. E. Bates, and J. B. Clark, Heightened resistance of the neonatal brain to ischemia-reperfusion involves a lack of mitochondrial damage in the nerve terminal, Brain Res. 821, 124-133 (1999).
17. N. A. Berger, Cellular response to DNA damage the role of poly(ADP-ribose), Radiat. Res. 101, 4-15 (1985).
18. 2+ block, Eur. J. Pharmacol. 278, 5565 (1995).
19. M. J. Gutnick, B. W. Connors, and D. A. Prince, Mechanisms of neocortical epileptogenesis in vitro, J. Neurophysiol. 48, 1321-1335 (1982).
20. C. J. Kilpatrick, S. M. Davis, B. M. Tress, et al., Epilectic seizures of acute stroke, Arch. Neurol. 47, 157-160 (1990).
21. V. L. Dawson, T. M. Dawson, E. D. Lonon, et al., Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures, Proc. Natl. Acad. Sci. USA 88, 6368-6371 (1991).
22. J. P. Nowicki, D. Duwal, H. Poignet, et al., Nitric oxide mediates neuronal death after focal cerebral ischemia in mouse, Eur. J. Pharmacol. 204, 339-340 (1991).
23. B. Moghaddam, Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex: comparison to hippocampus and basal ganglia, J. Neurochem. 60, 1650-1657 (1993).
24. L. M. Jose, M. R. Olivenza, A. M. Mara, et al., Glutathion depletion, lipid peroxidation and mitochondrial disfunction are induced by chronic stress on rat brain, Neuropsychopharmacology 24, 420-429 (2001).
25. K. Abe, N. Hyashi, and H. Terada, Effect of endogenous nitric oxide on energy metabolism of rat heart mitochondria during ischemia and reperfusion, Free Radical Biol. Med. 26, 379-387 (1999).
26. K. L. Almeida, T. E. Allen, Bates, et al., Effect of reperfusion following cercberal ischemia on the activity of mitochondrial respiratory chain in the gerbil brain, J. Neurochem. 65, 1698-1703 (1995).
27. C. Bowling and M. F. Beal, Bioenergetics and oxidative stress in neurodegenerative diseases, Life. Sci. 56, 1151-1171 (1995).
28. D. J. O'Donovan and C. J. Fernandes, Mitochondrial glutathion and oxidative stress: implications for pulmonary oxygen toxicity in premature infants, Mol. Genet. Metab. 71, 325-328 (2000).
29. K. S. Zafar, A. Siddiqui, I. Syeed, et al., Dose dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences, J. Neurochem. 84, 438-446 (2003).
30. J. T. Rotruck, A. L. Pope, H. E. Ganther, et al., Selenium: biochemical role as a componen of glutathione peroxidase, Science 233, 539-544 (1973).
31. N. Q. Li, P. S. Reddy, K. Thyagaraju, et al., Elevation of rat liver mRNA for selenium-dependent glutathione peroxidase by selenium deficiency, J. Biol. Chem. 265, 108-113 (1990).
32. V. G. Desai, D. Casciano, R. J. Feuers, et al., Activity profile of glutathione-dependent enzymes and respiratory chain complexes in rats supplemented with antioxidants and treated with carcinogens, Arch. Biochem. Biophys. 394, 255-264 (2001).
33. F. Islam, S. Zia, I. Sayeed, et al., Selenium-induced alteration of lipids, lipid peroxidation, and thiol group in circadian rhythm centers of rat, Biol. Trace Element Res. 90, 203-214 (2002).
34. P. A. Wolf, W. B. Kannel, and J. Verter, Current status of risk factors for stroke, Neurol. Clin. North Am. 1, 317-318 (1983).
35. E. D. Hall, P. K. Andrus, J. A. Oostveen, et al., Neuroprotective effects of the dopamine D2/D3 against pramipexole against postischemic or methamphetamine-induced degeneration of nigostriatal neurons, Brain Res. 742, 80-88 (1996).
36. S. G. Simonson, J. Zhang, A. T. Canada, et al., Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain, Cereb. Blood Flow Metab. 13, 125-134 (1993).
37. M. Kozuka and N. Iwata, Changes in levels of monoamines and their metabolites in incompletely ischemic brains of spontaneously hypertensive rats, Neurochem. Res. 20, 1429-1435 (1995).
38. T. Tadano, A. Yonezawa, K. Oyama, et al., Effect of transient global ischemia and a monoamine oxidase inhibitor ifenprodil on rat brain monoamine metabolism, Prog. Brain Res. 106, 173-180 (1995).
39. The Parkinson Study Group, Effect of deprenyl on the progression of disability in early Parkinson's disease, N. Engl. J. Med. 321, 1364-1371 (1989).
40. S. Stvolinsky, M. Kukley, D. Dobrota, et al., Carnosine protects rats under global ischemia, Brain Res Bull. 53, 445-448 (2000).
41. T. Suzuki, N. Akaike, K. Ueno, et al., MAO inhibitors, clorgyline and lazabemide, prevent hydroxyl radical generation caused by brain ischemia/reperfusion in mice, Pharmacology 50, 357-362 (1995).
42. W. Zhong and T. D. Oberley, Redox-mediated effects of selenium on apoptosis and cell cycle in the LNCap human prostate cancer cell line, Cancer Res. 61, 7071-7078 (2001).
43. E. Z. Longa, P. R. Weinstein, S. Carlson, et al., Reversible middle cerebral artery occlusion without craniotomy in rats, Stroke. 20, 84-91 (1989).
44. A. Nagy, and A. V. Delgado-Escueta, Rapid preparation of synaptosomes from mammalion brain using nontoxic isoosmotic gradient material (percol), J. Neurochem. 43, 1114-1123 (1984).
45. D. J. Jollow, J. R. Mitchell, N. Zampagline, et al., Bromobenzene induced liver necrosis: protective role of glutathione and evidence for 3,4-bromobenzene as the hepatic metabolite, Pharmacology 11, 151-169 (1974).
46. J. Mohandas, J. J. Marshall, G. G. Duggins, et al., Differential distribution of glutathion and glutathione related enzymes in rabit kidney: possible implications in analgesic neuropathy, Cancer Res. 44, 5086-5091 (1984).
47. W. H. Habig, M. Pabst, and W. B. Jakoby, Glutathion-S-transferase: the first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249, 7130-7139 (1974).
48. M. Stevens, I. Obrosova, X. Cao, et al., Effects of DL-alpha-lipidic acid on peripheral nerve canduction, blood flow, energy metabolism and oxidative stress in experimental diabetic neuropathy, Diabetes 49, 1006-1015 (2000).
49. A. Claiborne, Catalase activity, in CRC Handbook of Methods for Oxygen Radical Research, R. A. Greenwold, ed., CRC, Boca Raton, FL, pp. 283-284 (1985).
50. H. C. Utley, F. Bernheim, and P. Hochslein, Effect of sulfhydryl reagent on peroxidation in micrisome, Arch. Biochem. Biophys. 260, 521-531 (1967).
51. M. Thakkar and B. N. Mallick, Effect of rapid eye movement sleep deprivation on rat brain monoamine oxidases, Neuroscience 55, 677-683 (1993).
52. A. Masmoudi, F. Islam, and P. Mandel, ADP-ribosylation of highly purified rat brain mitochondria, J. Neurochem. 51, 188-193 (1988).
53. B. P. Adlard, S. W. DeSouza, and S. Moon, The effect of age, grouth, retardation and asphyxia on ascorbic acid concentrations in developing brain, J. Neurochem. 21, 877-881 (1973).
54. I. Fridovich, The biology of oxygen radicals, Science 201, 875-880 (1978).
55. R. A. Floyd and J. M. Carney, Free radical damage to protein and DNA; mechanism involved and relevant observations on brain undergoing oxidative stress, Ann. Neurol. 32(Suppl.), S22-S27 (1992).
56. B. Halliwell, Reactive oxygen species and the central nervous system, J. Neurochem. 59, 1609-1623 (1992).
57. H. S. Park, S. H. Hoh, Y. Kim, et al., Selenite negatively regulates caspase-3 through a redox mechanism, J. Biol. Chem. 275(12), 8487-8491 (2000).
58. Y. Matsui and Y. Kumage, Monoamine oxidase inhibitors prevent strital neuronal necrosis induced by transient forebrain ischemia, Neurosci. Lett. 126, 175-178 (1991).
59. S. Z. Imam, G. D. Newport, F. Islam, et al., Selenium and antioxidant, protects against methamphatmins-induced dopaminergic neurotoxicity, Brain Res. 818, 575-578 (1999).